People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotech / Pharma, Other, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PharmaCann Inc. | — | Biotech / Pharma | Series D+ | $509.0M | $413.1M | 2020 |
| Nasuni Corp | — | Other | Series C | $137.7M | $734.6M | 2016 |
| Wanderlust Group, Inc. | — | Other Technology | Series B | $57.1M | $550.2M | 2017 |
| Orderful Inc. | — | Other Technology | Series B | $35.5M | $24.4M | 2021 |
| Seasoned 2.0 Inc. | — | Other | Series A | $16.1M | $39.4M | 2021 |
| Attiva U.S.A., Inc. | — | Other Health Care | Pre-Seed | $200K | $1.3M | 2023 |
John McCarthy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John McCarthy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Davoli | 1 | 22 |
| David Campbell | 1 | 12 |
| David Ulevitch | 1 | 11 |
| Bart Swanson | 1 | 8 |
| Charles M. Hazard, Jr. | 1 | 7 |
| Jeffrey McCarthy | 1 | 7 |
| Paul Flanagan | 1 | 6 |
| James Barry | 1 | 5 |
| Peter McKay | 1 | 4 |
| Patrick Barry | 1 | 4 |
| Charles Hazard | 1 | 4 |
| John Leja | 1 | 4 |
| Scott Dussault | 1 | 3 |
| John Lord | 1 | 3 |
| Daniel Ward | 1 | 3 |
| Dean Breda | 1 | 3 |
| Andrew Wait | 1 | 3 |
| Jack Zamora | 1 | 2 |
| Daniel Roth | 1 | 2 |
| Andres Rodriguez | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.